Hepatocellular carcinoma (HCC), tí a tún pè ní malignant hepatoma, jẹ́ àrùn jẹjẹrẹ inú ẹ̀dọ tó wọ́pọ̀. Àwọn ìdí tí àrùn yìí lè fi wáyé ní nípasẹ̀ àkóràn kòkòrò jẹ̀dọ̀jẹ̀dọ̀ (Jẹ̀dọ̀jẹ̀dọ̀ B tàbí  C), àwọn ohun tó lòdì sára bíi ògógóró tàbí  aflatoxin, àwọn ìpò bíi  hemochromatosis àti alpha 1-antitrypsin deficiency or NASH. Kumar V, Fausto N, Abbas A (editors) (2015). "Long-term results of liver transplantation for hepatocellular carcinoma: an update of the University of Padova experience". September 23, 2013. Retrieved 6 February 2014.  Bruix, Jordi; Sherman, Morris; Practice Guidelines Committee (November 2005). "Management of hepatocellular carcinoma". Hepatology 42 (5): 1208–1236. doi:10.1002/hep.20933. PMID 16250051.  Liu, Chi-leung, M.D., "Hepatic Resection for Hepatocellular Carcinoma", The Hong Kong Medical Diary, Vol.10 No.12, December 2005 Medical Bulletin